A drinkable cocktail of designer molecules shows promise for Alzheimer's and Creutzfeldt-Jakob Disease

Amyloid beta plaques accumulated in a mouse hippocampus.

Yale researchers have identified a drinkable cocktail of designer molecules that interferes with a crucial first step of Alzheimer’s and even restores memories in mice, they report Jan. 2 in the journal Cell Reports.

The binding of amyloid beta peptides to prion proteins triggers a cascade of devasting events in the progression of Alzheimer’s — accumulation of plaques, a destructive immune system response, and damage to synapses.

“We wanted to find molecules that might have a therapeutic effect on this network,” said senior author Stephen Strittmatter, the Vincent Coates Professor of Neurology, professor of neuroscience, and director of the Yale Alzheimer Disease Research Center.

Strittmatter and research scientist Erik Gunther screened tens of thousands of compounds looking for molecules that might interfere with the damaging prion protein interaction with amyloid beta. They found that an old antibiotic looked like a promising candidate but was only active after decomposing to form a polymer. Related small polymers retained the benefit and also managed to pass through the blood-brain barrier.

They then dissolved the optimized polymeric compound and fed it to mice engineered to have a condition that mimics Alzheimer’s. They found that synapses in the brains were repaired and mice recovered lost memory.

A collaborating team at Dartmouth University reported a positive response when they delivered the same cocktail to cells modeled to have Creutzfeldt-Jakob Disease, a devasting neurological condition caused by infection with misfolded prion protein.

The next step is to verify the compounds aren’t toxic in preparation for translation to clinical trials for Alzheimer’s disease.

Learn more: New compound shows promise in treatment of Alzheimer’s

The Latest on: Designer molecules

via Google News

The Latest on: Designer molecules

INVEST Pitch Perfect winner spotlight: Systems Oncology’s AI tech yields trove of cancer drugs
on June 20, 2021 at 5:01 am
Systems Oncology has used its its artificial intelligence to discover small molecules in development under partnerships with large pharma companies. The R&D of the company, the biopharma startup ...
Approaching zero: super-chilled mirrors edge towards the borders of gravity and quantum physics
on June 20, 2021 at 4:59 am
The LIGO gravitational wave observatory in the United States is so sensitive to vibrations it can detect the tiny ripples in space-time called gravitational waves. These waves are caused by colliding ...
Understanding Frustration Could Lead to Better Medications
on June 20, 2021 at 4:19 am
Rice scientists’ atomic resolution protein models reveal new details about protein binding. Knowing precisely where proteins are frustrated could go a long way toward making better drugs. That’s one r ...
That’s so cool: Physicists chilled a 10-kilogram object to the edge of ‘absolute zero’
on June 18, 2021 at 7:40 am
Absolute zero” is where atoms and molecules stop moving entirely. Quantum mechanics says the complete absence of motion is not really possible (due to the uncertainty principle).
Regulating Cellular Communication To Understand Disease
on June 18, 2021 at 1:44 am
A study has proposed a new strategy for the development of drugs based on the inhibition of tyrosine kinase enzymes, molecules that activate and trigger many cellular processes.
Scientists propose a new strategy to regulate the cell communication network
on June 17, 2021 at 1:39 pm
A study performed by researchers at the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC) from the Spanish National Research Council (CSIC) in collaboration with Stony Brook University (U.S.) ...
Novel magnet design with mirror-like properties
on June 11, 2021 at 7:33 am
Researchers at Tohoku University have demonstrated the designability of novel magnets with magic mirror-like characteristics in organic-inorganic hybrid perovskite (OIHP)-type compounds.
Novel magnet design with magic mirror-like properties
on June 10, 2021 at 9:00 pm
Researchers at Tohoku University have demonstrated the designability of novel magnets with magic mirror-like characteristics in organic-inorganic hybrid perovskite (OIHP)-type compounds.
CHEMriya - Billions of Molecules for R&D: OTAVA and BioSolveIT Team Up
on June 9, 2021 at 3:30 pm
Canadian-based compound specialist OTAVA (aka OTAVAchemicals) and German frontrunner cheminformatics firm BioSolveIT announce ...
Design Therapeutics to Participate in Goldman Sachs 42nd
on June 9, 2021 at 3:15 am
Body> CARLSBAD, Calif., June 07, 2021 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a biotechnology company developing treatments for degenerative genetic disorders, today reported ...